EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome



Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome



Lancet 337(8734): 138-140



(It has been established that strains of Escherichia coli O157:H7 producing Verocytotoxins are causative agents of haemolytic uraemic syndrome (HUS). However, these organisms are often only able to be isolated from faecal cultures from patients during the early stages of the infections. Even if the organisms are isolated it is still a major undertaking to establish that they are Verocytotoxigenic Esch. coli (VTEC).

(PDF 0-2 workdays service: $29.90)

Accession: 002219440

Download citation: RISBibTeXText

PMID: 1670788



Related references

The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome. Epidemiology and Infection 107(2): 349-356, 1991

Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection. Archives of Disease in Childhood 92(9): 820-823, 2007

Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection?. Archives of Disease in Childhood 93(2): 180-181, 2008

Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. The Osaka HUS Critical Care Study Group. Journal of Infection 41(1): 45-49, 2000

Serological identification of Escherichia coli 0157 as cause of haemolytic uraemic syndrome in Netherlands. Lancet 337(Feb. 16): 437, 1991

Improved detection of infection by Escherichia coli O157 in patients with haemolytic uraemic syndrome by means of IgA antibodies to lipopolysaccharide. Journal of Infection 24(3): 257-261, 1992

Using antibiotics in suspected haemolytic-uraemic syndrome: antibiotics should not be used in Escherichia coli O157:H7 infection. Bmj 330(7501): 1209; Author Reply 1209-1209; Author Reply 1209, 2005

Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome. Epidemiology and Infection 144(15): 3305-3315, 2016

Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. European Journal of Clinical Microbiology & Infectious Diseases 22(12): 726-730, 2003

Gender and the progression of Escherichia coli O157:H7 enteritis to haemolytic uraemic syndrome. Archives of Disease in Childhood 66(1): 171-172, 1991

Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse. Lancet 1(8584): 526-526, 1988

Characterization of Escherichia coli O157 : H7 isolates causing haemolytic uraemic syndrome in France. Journal of Medical Microbiology 54(Pt 1): 71-75, 2004

Characterization of Escherichia coli O157: H7 isolates causing haemolytic uraemic syndrome in France. Journal of Medical Microbiology 54(1): 71-75, 2005